(Q51952494)

18 April 2018

title

Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. (English)

1 reference

18 April 2018

0 references

0 references

1 reference

Vallabh Janardhan

1

1 reference

18 April 2018

Rohit Bakshi

series ordinal

2

1 reference

18 April 2018

publication date

1 December 2002

1 reference

18 April 2018

Journal of the Neurological Sciences

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 April 2018

volume

205

1 reference

18 April 2018

issue

1

1 reference

18 April 2018

page(s)

51-58

1 reference

18 April 2018

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

1 reference

Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Burden of illness of multiple sclerosis: Part I: Cost of illness. The Canadian Burden of Illness Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Quality of life in multiple sclerosis: measuring the disease effects more broadly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Quality of life as a predictor for change in disability in MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

The interrelations between disability and quality of life in patients with multiple sclerosis in the area of Bajo Aragon, Spain: a geographically based survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Determinants of overall quality of life in secondary progressive MS: a longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Fatigue in multiple sclerosis and its relationship to depression and neurologic disability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Affective disorders in multiple sclerosis. Review and recommendations for clinical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Impact of aerobic training on fitness and quality of life in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Treatment with weak electromagnetic fields improves fatigue associated with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Validation of Italian multiple sclerosis quality of life 54 questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Defining the clinical course of multiple sclerosis: Results of an international survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Fatigue in Multiple Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Quality of life in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Major depression and quality of life in individuals with multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Brain MRI lesions and atrophy are related to depression in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

Fatigue in MS is associated with specific clinical features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900312-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00312-X

1 reference

18 April 2018

1 reference

18 April 2018